{"url":"https://lda.senate.gov/api/v1/filings/61762f00-0803-4a73-9961-e65ffbddeb49/","filing_uuid":"61762f00-0803-4a73-9961-e65ffbddeb49","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2023,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/61762f00-0803-4a73-9961-e65ffbddeb49/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brian Lopina","dt_posted":"2024-01-17T17:56:34-05:00","termination_date":"2023-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3305 Bywater Ct.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Oak Hill","registrant_state":"VA","registrant_zip":"20171","registrant":{"id":401103314,"url":"https://lda.senate.gov/api/v1/registrants/401103314/","house_registrant_id":null,"name":"LUNGREN LOPINA LLC","description":"government relations","address_1":"3305 Bywater Ct.","address_2":null,"address_3":null,"address_4":null,"city":"Oak Hill","state":"VA","state_display":"Virginia","zip":"20171","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRIAN LOPINA","contact_telephone":"+1 202-460-2564","dt_updated":"2025-01-11T13:43:06.626565-05:00"},"client":{"id":198545,"url":"https://lda.senate.gov/api/v1/clients/198545/","client_id":63,"name":"AMPAC FINE CHEMICALS","general_description":"Manufactures active pharmaceutical ingredients and registered intermediates for pharma","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-09-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Fair treatment for US based pharmaceutical ingredients","foreign_entity_issues":"A general interest in the success of AMPAC Fine Chemicals","lobbyists":[{"lobbyist":{"id":62106,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"LUNGREN","suffix":null,"suffix_display":null},"covered_position":"Member of Congress","new":false},{"lobbyist":{"id":60510,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"LOPINA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"SK HOLDINGS","contribution":"0.00","ownership_percentage":"100.00","address":"26, Jong-ro, Jongno-gu","city":"Seoul","state":null,"state_display":null,"country":"KR","country_display":"South Korea","ppb_city":"Seoul","ppb_state":null,"ppb_state_display":null,"ppb_country":"KR","ppb_country_display":"South Korea"}],"affiliated_organizations":[]}